Last week, the Trump administration imposed 100% tariffs on patented pharmaceutical products and ingredients. Imports of pharmaceuticals from China are largely generics, though, and may not feel much impact from these tariffs.

On March 25, China's Ministry of Commerce (MOFCOM) released its final conclusion regarding the trade and investment barrier investigation into restrictive measures implemented by the Mexican government, reaching the conclusion that Mexico's recent tariff increases on products from non-Free Trade Agreement (FTA) partners, specifically targeting Chinese

After the Supreme Court struck down President Trump's IEEPA tariffs, his administration immediately turned to Section 122 of the Trade Act of 1974 for replacement tariffs (to be supplemented by additional tariffs under Section 301 of that same statute, as well as Section 232 of the Trade Expansion

Today, China's Ministry of Commerce said that it is still weighing the implications of a U.S. Supreme Court decision striking down President Donald Trump's use of emergency powers to impose sweeping tariffs, while closely monitoring new tariff developments.

In a major development related to the Trump administration's tariff strategy, on Friday the Supreme Court held that the International Emergency Economic Powers Act (IEEPA), under which the Trump administration had justified many of its tariffs on China and other countries, does not allow the president to impose

China will eliminate tariffs on all products from 53 African nations this spring, President Xi Jinping announced in a message sent last week to the African Union (AU) Summit.

Amid positive momentum between Beijing and Ottawa on resolving a string of trade disputes, China's Ministry of Commerce (MOFCOM) signaled an adjustment to its anti-discrimination measures targeting Canada and an extension of the anti-dumping investigation on canola seeds, with new announcements expected in the coming weeks.